The 16th patient in a study of the Neuro-Spinal Scaffold has been enrolled by InVivo Therapeutics at Allegheny General Hospital in Pittsburgh. The study seeks to assess the device's safety and efficacy in treating patients with complete thoracic AIS A spinal cord injury.
Study advances for InVivo Therapeutics' neurospinal scaffold
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.